685 related articles for article (PubMed ID: 29735758)
1. Impact of Active Metabolism on Chlamydia trachomatis Elementary Body Transcript Profile and Infectivity.
Grieshaber S; Grieshaber N; Yang H; Baxter B; Hackstadt T; Omsland A
J Bacteriol; 2018 Jul; 200(14):. PubMed ID: 29735758
[TBL] [Abstract][Full Text] [Related]
2. Computational Modeling of the Chlamydial Developmental Cycle Reveals a Potential Role for Asymmetric Division.
Chiarelli TJ; Grieshaber NA; Appa C; Grieshaber SS
mSystems; 2023 Apr; 8(2):e0005323. PubMed ID: 36927072
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms.
Saka HA; Thompson JW; Chen YS; Kumar Y; Dubois LG; Moseley MA; Valdivia RH
Mol Microbiol; 2011 Dec; 82(5):1185-203. PubMed ID: 22014092
[TBL] [Abstract][Full Text] [Related]
4. Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle.
Shaw EI; Dooley CA; Fischer ER; Scidmore MA; Fields KA; Hackstadt T
Mol Microbiol; 2000 Aug; 37(4):913-25. PubMed ID: 10972811
[TBL] [Abstract][Full Text] [Related]
5. The ClpX and ClpP2 Orthologs of Chlamydia trachomatis Perform Discrete and Essential Functions in Organism Growth and Development.
Wood NA; Blocker AM; Seleem MA; Conda-Sheridan M; Fisher DJ; Ouellette SP
mBio; 2020 Sep; 11(5):. PubMed ID: 32873765
[No Abstract] [Full Text] [Related]
6. The molecular biology and diagnostics of Chlamydia trachomatis.
Birkelund S
Dan Med Bull; 1992 Aug; 39(4):304-20. PubMed ID: 1526183
[TBL] [Abstract][Full Text] [Related]
7. Differential Effects of Small Molecule Inhibitors on the Intracellular Chlamydia Infection.
Muñoz KJ; Tan M; Sütterlin C
mBio; 2022 Aug; 13(4):e0107622. PubMed ID: 35703434
[TBL] [Abstract][Full Text] [Related]
8. The Periplasmic Tail-Specific Protease, Tsp, Is Essential for Secondary Differentiation in
Swoboda AR; Wood NA; Saery EA; Fisher DJ; Ouellette SP
J Bacteriol; 2023 May; 205(5):e0009923. PubMed ID: 37092988
[TBL] [Abstract][Full Text] [Related]
9. The sRNA Regulated Protein DdbA Is Involved in Development and Maintenance of the Chlamydia trachomatis EB Cell Form.
Grieshaber NA; Runac J; Turner S; Dean M; Appa C; Omsland A; Grieshaber SS
Front Cell Infect Microbiol; 2021; 11():692224. PubMed ID: 34368013
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the Protein Phosphatase CppA Alters Development of Chlamydia trachomatis.
Claywell JE; Matschke LM; Plunkett KN; Fisher DJ
J Bacteriol; 2018 Oct; 200(19):. PubMed ID: 30038048
[TBL] [Abstract][Full Text] [Related]
11. Single-Inclusion Kinetics of
Chiarelli TJ; Grieshaber NA; Omsland A; Remien CH; Grieshaber SS
mSystems; 2020 Oct; 5(5):. PubMed ID: 33051378
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Proteomics of the Infectious and Replicative Forms of Chlamydia trachomatis.
Skipp PJ; Hughes C; McKenna T; Edwards R; Langridge J; Thomson NR; Clarke IN
PLoS One; 2016; 11(2):e0149011. PubMed ID: 26871455
[TBL] [Abstract][Full Text] [Related]
13. Developmental stage-specific metabolic and transcriptional activity of Chlamydia trachomatis in an axenic medium.
Omsland A; Sager J; Nair V; Sturdevant DE; Hackstadt T
Proc Natl Acad Sci U S A; 2012 Nov; 109(48):19781-5. PubMed ID: 23129646
[TBL] [Abstract][Full Text] [Related]
14. The Repressor Function of the
Zhang Q; Rosario CJ; Sheehan LM; Rizvi SM; Brothwell JA; He C; Tan M
J Bacteriol; 2020 Mar; 202(8):. PubMed ID: 31988079
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle.
Wolf K; Betts HJ; Chellas-Géry B; Hower S; Linton CN; Fields KA
Mol Microbiol; 2006 Sep; 61(6):1543-55. PubMed ID: 16968227
[TBL] [Abstract][Full Text] [Related]
16. Tag-Dependent Substrate Selection of ClpX Underlies Secondary Differentiation of Chlamydia trachomatis.
Wood NA; Swoboda AR; Blocker AM; Fisher DJ; Ouellette SP
mBio; 2022 Oct; 13(5):e0185822. PubMed ID: 36154190
[TBL] [Abstract][Full Text] [Related]
17. Expression and structure of the Chlamydia trachomatis DksA ortholog.
Mandel C; Yang H; Buchko GW; Abendroth J; Grieshaber N; Chiarelli T; Grieshaber S; Omsland A
Pathog Dis; 2022 May; 80(1):. PubMed ID: 35388904
[TBL] [Abstract][Full Text] [Related]
18. One Face of Chlamydia trachomatis: The Infectious Elementary Body.
Cossé MM; Hayward RD; Subtil A
Curr Top Microbiol Immunol; 2018; 412():35-58. PubMed ID: 27197644
[TBL] [Abstract][Full Text] [Related]
19. Penicillin induced persistence in Chlamydia trachomatis: high quality time lapse video analysis of the developmental cycle.
Skilton RJ; Cutcliffen LT; Barlow D; Wang Y; Salim O; Lambden PR; Clarke IN
PLoS One; 2009 Nov; 4(11):e7723. PubMed ID: 19893744
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism.
Fields KA; Hackstadt T
Mol Microbiol; 2000 Dec; 38(5):1048-60. PubMed ID: 11123678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
